Healthcare & Medical Devices Global On demand · 24-48h

Global Blood Microsampling Devices Market Strategic Research Report

Global Blood Microsampling Devices Market Strategic Research…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Blood Microsampling Devices Market
$94.512025
14.3%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Dried Blood Samples, Liquid Blood Sampless

By Application: Disease Diagnostics, Health Screening, Clinical Research, Others

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Tasso, Trajan Group, YourBio Health, Capitainer, BD, Spot On Sciences, RedDrop Dx, Owen Mumford, RDA Spot, PanoHealth, Hemaxis, Drawbridge Health, Lipomic Healthcare, Lameditech, Mindray Bio-Medical Electronics

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 114 pages
Market size 2025
$94.51
Million USD
Forecast CAGR
14.3%
2025-2032
Forecast 2032
$240.9
Projected
영역들
5
Asia Pacific · Latin America · MEA · Europe · North America

개요

Scope of the Report

The global Blood Microsampling Devices market size is predicted to grow from US$ 94.51 million in 2025 to US$ 244 million in 2032; it is expected to grow at a CAGR of 14.3% from 2026 to 2032.

Blood Microsampling Devices are medical devices or consumables designed to collect very small volumes of blood from sites such as the fingertip, upper arm, or other superficial areas, serving as an alternative to certain conventional venous blood collection methods. They feature low sample volume, minimal invasiveness, ease of use, and suitability for home-based or remote sampling, and are widely used in therapeutic drug monitoring, clinical testing, chronic disease management, pediatric testing, biomarker analysis, and clinical research. In 2025, global Blood Microsampling Devices production reached approximately 9088.3 k units, with an average global market price of around 10.6 USD/unit,.The production capacity for Blood Microsampling Devices in 2025 was approximately 10000 k units The typical gross profit margin for Blood Microsampling Devices between 20% and 40%.

The Blood Microsampling Devices market is driven by the growth of telemedicine, home-based testing, precision medicine, decentralized clinical trials, and chronic disease management. The market is shifting from conventional laboratory-based blood collection toward more convenient, minimally invasive, and decentralized sampling models. As pharmaceutical companies, CROs, diagnostic laboratories, and healthcare providers increasingly require low-volume sample collection, stable sample preservation, and improved patient compliance, the adoption of microsampling cards, capillary collection devices, microneedle-based devices, and wearable sampling solutions is expanding, although sample standardization, assay sensitivity, regulatory approval, and laboratory workflow integration remain key challenges.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Blood Microsampling Devices market?

What factors are driving Blood Microsampling Devices market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Blood Microsampling Devices market opportunities vary by end market size?

How does Blood Microsampling Devices break out by Type, by Application?

This report presents a comprehensive overview of the global Blood Microsampling Devices market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Dried Blood Samples
  • Liquid Blood Sampless

Segment by Sampling Volume

  • Ultra-low Volume Devices: <10 μL
  • Low Volume Devices: 10–50 μL
  • Medium-High Volume Devices: >50 μL

Segment by Application

  • Disease Diagnostics
  • Health Screening
  • Clinical Research
  • Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Blood Microsampling Devices market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Disease Diagnostics, Health Screening, Clinical Research evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Blood Microsampling Devices Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 14.3%
Regional growth momentum
Market share by segment
Key metrics
Base value
$94.51
2025
Forecast
$240.9
2032
CAGR
14.3%
2025–2032
영역들
5
global
Key companies
TassoTrajan GroupYourBio HealthCapitainerBDSpot On SciencesRedDrop DxOwen Mumford
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Dried Blood SamplesLiquid Blood Sampless
By Application
Disease DiagnosticsHealth ScreeningClinical ResearchOthers

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Dried Blood Samples
  • 3.1.3 Liquid Blood Sampless
  • 3.1.4 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Disease Diagnostics
  • 4.1.3 Health Screening
  • 4.1.4 Clinical Research
  • 4.1.5 Others
  • 4.1.6 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Tasso
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Trajan Group
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 YourBio Health
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Capitainer
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 BD
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Spot On Sciences
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 RedDrop Dx
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Owen Mumford
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 RDA Spot
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 PanoHealth
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Hemaxis
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Drawbridge Health
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Lipomic Healthcare
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 Lameditech
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Mindray Bio-Medical Electronics
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the current global Blood Microsampling Devices market size?
The global Blood Microsampling Devices market is estimated at US$ 94.51 million in 2025 (base year) and is projected to reach US$ 244 million by 2032.
What growth rate is expected for the Blood Microsampling Devices market through 2032?
The market is expected to grow at a CAGR of 14.3% from 2026 to 2032, expanding from US$ 94.51 million in 2025 to US$ 244 million in 2032, roughly 2.6 times its base-year value.
How is Blood Microsampling Devices defined?
Blood Microsampling Devices are medical devices or consumables designed to collect very small volumes of blood from sites such as the fingertip, upper arm, or other superficial areas, serving as an alternative to certain conventional venous blood collection methods. They feature low sample volume, minimal invasiveness, ease of use, and suitability for home-based or remote sampling, and are widely used in therapeutic drug monitoring, clinical testing, chronic disease management, pediatric testing, biomarker analysis, and clinical research.
What are the main segments of the Blood Microsampling Devices market by type?
By type, the market is segmented into Dried Blood Samples and Liquid Blood Sampless.
Which applications drive demand in the Blood Microsampling Devices market?
Key applications covered include Disease Diagnostics, Health Screening, Clinical Research and Others.
Who are the key players in the Blood Microsampling Devices market?
Key players profiled include Tasso, Trajan Group, YourBio Health, Capitainer, BD, Spot On Sciences, RedDrop Dx and Owen Mumford, among 15 companies covered in total.
Which regions and countries are covered for Blood Microsampling Devices?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What is driving growth in the Blood Microsampling Devices market?
The Blood Microsampling Devices market is driven by the growth of telemedicine, home-based testing, precision medicine, decentralized clinical trials, and chronic disease management.
Who should buy the Blood Microsampling Devices market report?
The report is intended for manufacturers and solution providers, distributors and end users in Disease Diagnostics, Health Screening and Clinical Research, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Blood Microsampling Devices market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from US$3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.